Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SDD in Esophageal Cancer Surgery
NCT05865743Phase 3Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2024
- Primary completion
- Dec 2027
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of amphotericin b, colistin, tobramycin in esophageal cancer, sponsored by Radboud University Medical Center. Started Oct 2024; status: recruiting.
02
Drugs
amphotericin bcolistintobramycin
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT05865743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05865743.